Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 132INDUSTRY 32NIH 19NETWORK 2UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 2Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1

Interventions

Cytarabine 30Daunorubicin 15Gene Expression Profiling 9Gemtuzumab 9Flow Cytometry 9Idarubicin 8Mitoxantrone 7sargramostim 6fludarabine 6Polymerase Chain Reaction 6Methotrexate 6Filgrastim 6Etoposide 6Cyclophosphamide 6Busulfan 6fludarabine phosphate 5Specimen Handling 5merphos 4Whole-Body Irradiation 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Biopsy 4Tacrolimus 3Observation 3Melphalan 3Immunologic Techniques 3Hydrocortisone 3DNA Methylation 3Clofarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myeloid, Acute × Decitabine × Clear all
NCT02085408 2024-12-13

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Eastern Cooperative Oncology Group

Phase 3 Completed
727 enrolled 13 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02172872 2023-02-15

"InDACtion" vs "3+7" Induction in AML

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
606 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡